Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open Label, Dose Finding Study of the Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer Compared to a Luteinizing Hormone Releasing Hormone Agonist

NCT01326312 is registered in ClinicalTrials.gov with GTx as lead sponsor.

NCT NCT01326312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01326312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open Label, Dose Finding Study of the Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer Compared to a Luteinizing Hormone Releasing Hormone Agonist
Lead sponsor
GTx
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2011
Completion date
December 31, 2012
Enrollment
159 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer